Humacyte Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.68

-0.10 (-13.21%)

As of Mar 29, 10:36 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 85%

Hold 2 15%

Sell 0 0%

Price Target

Analyst Price Target +2,152.8% upside

Low Target $10.64

Average Target $15.22

High Target $24.41

Current Price $0.68

Current
$0.68

Target
$15.22

$10.64 $15.22 avg $24.41

Scenario Analysis

Bear Case

$10.64

1,474.9%

Low target

Base Case

$15.22

+2,152.8%

Avg target

Bull Case

$24.41

+3,513.1%

High target

Risk/Reward

2.4x

Favorable

Price in Context

52-Week High

$2.93

-76.9% from high

52-Week Low

$0.70

+-3.6% from low

Target vs 52W High

$15.22

+419.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+19.8%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.0%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+158.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-13.0%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-29.7%